Active surveillance for low-risk prostate cancer

Area of Science:

• Urology and Oncology
• Prostate Cancer Management

Background:

• Standard treatments for prostate cancer (surgery, radiation) significantly impact patient quality of life, affecting sexual and urinary functions.
• Active surveillance programs identify low-risk prostate cancer patients, delaying or selectively applying curative therapies.
• Current data indicate that delayed treatment does not negatively affect clinical outcomes in carefully selected prostate cancer patients.

Purpose of the Study:

• To evaluate the efficacy and impact on quality of life of active surveillance for low-risk prostate cancer.
• To explore the role of molecular determinants in predicting prostate cancer behavior and identifying therapeutic targets.

Main Methods:

• Review of recent data and clinical experiences with active surveillance programs for prostate cancer.
• Analysis of risk stratification methods for identifying suitable candidates for active surveillance.
• Exploration of molecular factors influencing prostate cancer progression and treatment response.

Main Results:

• A limited number of patients managed under active surveillance require subsequent treatment.
• Delayed therapeutic intervention in highly selected prostate cancer patients does not appear to alter clinical outcomes.
• Understanding molecular determinants is crucial for personalized treatment decisions.

Conclusions:

• Active surveillance is a viable strategy for managing low-risk prostate cancer, preserving quality of life.
• Molecular profiling can enhance the identification of patients who need aggressive treatment versus those suitable for surveillance.
• Further research into molecular targets may lead to novel therapeutic strategies for prostate cancer.